About:
Apaxon Biotech LLC is focused on identifying blood-based biomarkers for Parkinson's disease. The research at Apaxon Biotech focuses on developing therapeutic antibodies against Parkinson's Disease and other protein aggregation diseases. The company is performing a pilot study to collect blood samples from PD patients to test their innovation biomarker identification test. This test uses recombinant protein technology and a new class of antibodies to create a rapid test that is easy to use.